{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:42:11Z","timestamp":1777329731521,"version":"3.51.4"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Neurofibromatosis type 1 (NF1) is a neurocutaneous syndrome caused by mutations on the\n                    <jats:italic>NF1<\/jats:italic>\n                    gene, which is located at chromosome 17q11.2. Although an autosomal dominant inheritance pattern is well-established, about half of new cases are the result of\n                    <jats:italic>de novo NF1<\/jats:italic>\n                    mutations. Neurofibromatosis type 1 has an incidence rate of 1\/2600\u20133000 individuals, making it a major public health problem. The product of the\n                    <jats:italic>NF1<\/jats:italic>\n                    gene, the neurofibromin protein, is known to play a critical role in cellular differentiation and in tumor suppression. Due to widespread expression of neurofibromin in numerous tissues, particularly in cutaneous and nervous systems,\n                    <jats:italic>NF1<\/jats:italic>\n                    mutations cause a wide variety of clinical symptoms, including cutaneous and ocular lesions such as caf\u00e9 au lait spots, axillary and inguinal freckling, multiple cutaneous neurofibromas, iris Lisch nodules, choroidal freckling and internal tumors. In this article, we report the cases of two siblings with NF1, a 21-year-old male and his 24-year-old sister, who have the same c.5392C&gt;T mutation on the\n                    <jats:italic>NF1<\/jats:italic>\n                    gene (p.Gln1798 Ter). Caf\u00e9 au lait macules and freckling were the prominent clinical features in both siblings. However, a plexiform neurofibroma was also observed on the left arm of the sister, which is known to carry potential risk for malignant transformation. Although the mutation was previously described once, to the best of our knowledge, no case report has been published since then.\n                  <\/jats:p>","DOI":"10.2478\/bjmg-2021-0021","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T17:05:00Z","timestamp":1654362300000},"page":"99-102","source":"Crossref","is-referenced-by-count":2,"title":["Case Report for Two Siblings Carrying Neurofibromatosis Type 1 with a Rare\n                    <i>NF1<\/i>\n                    : c.5392C&gt;T Mutation"],"prefix":"10.2478","volume":"24","author":[{"given":"DB","family":"Say\u0131n Kocakap","sequence":"first","affiliation":[{"name":"Department of Medical Genetics , K\u0131r\u0131kkale University Faculty of Medicine , K\u0131r\u0131kkale , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[{"name":"Department of Dermatology , K\u0131r\u0131kkale University Faculty of Medicine , K\u0131r\u0131kkale , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"\u00d6zer","sequence":"additional","affiliation":[{"name":"Mikrogen Genetic Diagnostic Laboratory , Ankara , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Durak","sequence":"additional","affiliation":[{"name":"Department of Dermatology , K\u0131r\u0131kkale University Faculty of Medicine , K\u0131r\u0131kkale , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,6,5]]},"reference":[{"key":"2026042718395026363_j_bjmg-2021-0021_ref_001","unstructured":"Friedman JM. Neurofibromatosis 1. GeneReviews\u00ae. Adam MP, Ardinger HH, Pagon RA, et al., Editors. Seattle, WA, USA: University of Washington, Seattle; 1993\u20132021. [Accessed July 2021] Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1109\/."},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_002","doi-asserted-by":"crossref","unstructured":"Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 2005; 141(1): 71\u201374.","DOI":"10.1001\/archderm.141.1.71"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_003","doi-asserted-by":"crossref","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010; 152A(2): 327\u2013332.","DOI":"10.1002\/ajmg.a.33139"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_004","doi-asserted-by":"crossref","unstructured":"Yang F, Xu S, Liu R, Shi T, Li X, Li X, et al. The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing. Onco Targets Ther. 2018; 11: 919\u2013932.","DOI":"10.2147\/OTT.S156998"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_005","doi-asserted-by":"crossref","unstructured":"Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet. 1996; 33(1): 2\u201317.","DOI":"10.1136\/jmg.33.1.2"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_006","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405\u2013424.","DOI":"10.1038\/gim.2015.30"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_007","doi-asserted-by":"crossref","unstructured":"Anastasaki C, Le LQ, Kesterson RA, Gutmann DH. Updated nomenclature for human and mouse neurofibromatosis type 1 genes. Neurol Genet. 2017; 3(4): e169.","DOI":"10.1212\/NXG.0000000000000169"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_008","unstructured":"Cooper DN, Ball EV, Stenson PD, Phillips AD, Evans K, Heywood S, et al. The human gene mutation database at the Institute of Medical Genetics in Cardiff. [Accessed February 2021] Available at: http:\/\/www.hgmd.cf.ac.uk\/ac\/gene.php?gene=NF1)."},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_009","doi-asserted-by":"crossref","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, et al. VarSome: The Human Genomic Variant Search Engine. Bioinformatics. 2019; 35(11): 1978\u20131980. doi: 10.1093\/bioinformatics\/bty897.bty897. [Accessed October 2018].","DOI":"10.1093\/bioinformatics\/bty897"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_010","doi-asserted-by":"crossref","unstructured":"Zhu G, Zheng Y, Liu Y, Yan A, Hu Z, Yang Y, et al. Identification and characterization of NF1 and no-NF1 congenital pseudoarthrosis of the tibia based on germline NF1 variants: Genetic and clinical analysis of 75 patients. Orphanet J Rare Dis. 2019; 14(1): 221.","DOI":"10.1186\/s13023-019-1196-0"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_011","doi-asserted-by":"crossref","unstructured":"Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986; 57(10): 2006\u20132021.","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_012","doi-asserted-by":"crossref","unstructured":"Sharafi P, Ayter S. Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes. J Neurogenet. 2018; 32(2): 65\u201377.","DOI":"10.1080\/01677063.2018.1456538"},{"key":"2026042718395026363_j_bjmg-2021-0021_ref_013","doi-asserted-by":"crossref","unstructured":"Pasmant E, Vidaud M, Vidaud D, Wolkenstein P. Neurofibromatosis type 1: From genotype to phenotype. J Med Genet. 2012;49(8): 483\u2013489.","DOI":"10.1136\/jmedgenet-2012-100978"}],"container-title":["Balkan Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/bjmg-2021-0021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:05:58Z","timestamp":1777327558000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/bjmg-2021-0021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,5]]},"published-print":{"date-parts":[[2021,11,1]]}},"alternative-id":["10.2478\/bjmg-2021-0021"],"URL":"https:\/\/doi.org\/10.2478\/bjmg-2021-0021","relation":{},"ISSN":["1311-0160"],"issn-type":[{"value":"1311-0160","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}